Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...
Verywell Health on MSN8d
What Causes Postpartum Hypertension (and How to Treat It)?Hypertension in pregnancy increases the likelihood of postpartum hypertension. Know the risk factors to start managing ...
Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines ...
Keros Therapeutics said on Wednesday it would voluntarily halt testing of an experimental blood pressure treatment due to ...
Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including ...
Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...
While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...
The advancements of 2024 mark an exciting shift in high blood pressure treatment. With new medications, personalized care ...
A new treatment, Sotatercept, for pulmonary arterial hypertension (PAH) has recently been approved by the MHRA ...
Servier India Pvt. Ltd. has launched a single-pill combination (SPC) of Bisoprolol/Perindopril in India under the brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback